Zoom in: Haleon's Richmond facility is the company's R&D Center of Excellence, specializing in formulation development, ...

Haleon to invest $54 mln in US R&D centre to ... invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.

Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could cause sleepiness, TopClassAction ...

Haleon PLC HLN shares advanced 3.65% to £3.70 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 2.71% to 7,910.53 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pfizer sold its remaining 7.3% stake in Haleon for $3.1 billion, fully exiting its position in the company. Haleon expects 2025 organic revenue growth of 4% to 6%, with stronger performance in the ...

In trading on Monday, shares of Haleon plc (Symbol: HLN) crossed below their 200 day moving average of $9.72, changing hands as low as $9.19 per share. Haleon plc shares are currently trading down ...

Haleon plc (LON:HLN – Get Free Report)’s share price dropped 1.9% during trading on Monday .The stock traded as low as GBX 382.60 ($4.94) and last traded at GBX 385.50 ($4.98). Approximately ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon ...